Optimal Low-Density Lipoprotein Cholesterol Level: Time to Reconsider Stroke Subtypes.
作者信息
Kim Jong S
机构信息
Department of Neurology, Gangneung Asan Hospital, University of Ulsan, Gangneung, Korea.
出版信息
J Stroke. 2025 May;27(2):159-160. doi: 10.5853/jos.2025.02159. Epub 2025 May 31.
Abstract
摘要
相似文献
1
Optimal Low-Density Lipoprotein Cholesterol Level: Time to Reconsider Stroke Subtypes.最佳低密度脂蛋白胆固醇水平：是时候重新审视卒中亚型了。
J Stroke. 2025 May;27(2):159-160. doi: 10.5853/jos.2025.02159. Epub 2025 May 31.
2
Increased microvascular permeability and low level of low-density lipoprotein cholesterol predict symptomatic intracerebral hemorrhage in acute ischemic stroke.微血管通透性增加和低水平的低密度脂蛋白胆固醇可预测急性缺血性脑卒中的症状性颅内出血。
Sci Prog. 2020 Apr-Jun;103(2):36850420924153. doi: 10.1177/0036850420924153.
3
Genetically predicted small dense low-density lipoprotein cholesterol and ischemic stroke subtype: multivariable Mendelian randomization study.遗传预测小而密低密度脂蛋白胆固醇与缺血性脑卒中亚型：多变量孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 Jul 29;15:1404234. doi: 10.3389/fendo.2024.1404234. eCollection 2024.
4
Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes: A Mendelian Randomization Study.血脂在缺血性卒中及其亚型发病中的作用：一项孟德尔随机化研究。
Stroke. 2018 Apr;49(4):820-827. doi: 10.1161/STROKEAHA.117.019653. Epub 2018 Mar 13.
5
Achieved low-density lipoprotein cholesterol level and stroke risk: A meta-analysis of 23 randomised trials.达到的低密度脂蛋白胆固醇水平与中风风险：23项随机试验的荟萃分析
Eur J Prev Cardiol. 2021 Jul 23;28(8):905-916. doi: 10.1177/2047487319830503.
6
Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis.胆固醇水平与出血性卒中风险：系统评价和荟萃分析。
Stroke. 2013 Jul;44(7):1833-9. doi: 10.1161/STROKEAHA.113.001326. Epub 2013 May 23.
7
Small Dense Low-Density Lipoprotein Level in Newly Diagnosed Type 2 Diabetes Mellitus Patients With Normal Low-Density Lipoprotein.新诊断的低密度脂蛋白正常的2型糖尿病患者的小而密低密度脂蛋白水平
Cureus. 2023 Jan 18;15(1):e33924. doi: 10.7759/cureus.33924. eCollection 2023 Jan.
8
Intraindividual Discordance Between Remnant Cholesterol and Low-Density Lipoprotein Cholesterol Associated With Incident Stroke: Results From 2 National Cohorts.个体内残余胆固醇与低密度脂蛋白胆固醇的不匹配与卒中事件的相关性：来自 2 个全国队列的结果。
J Am Heart Assoc. 2024 Oct 15;13(20):e035764. doi: 10.1161/JAHA.124.035764. Epub 2024 Oct 11.
9
Non-high-density lipoprotein cholesterol: an important predictor of stroke and diabetes-related mortality in Japanese elderly diabetic patients.非高密度脂蛋白胆固醇：日本老年糖尿病患者卒中及糖尿病相关死亡的重要预测因子。
Geriatr Gerontol Int. 2012 Apr;12 Suppl 1:18-28. doi: 10.1111/j.1447-0594.2011.00809.x.
10
Relationship between serum lipid values and atherosclerotic burden in the proximal thoracic aorta.血清脂质值与胸主动脉近端粥样硬化负荷的关系。
Int J Stroke. 2010 Aug;5(4):257-63. doi: 10.1111/j.1747-4949.2010.00437.x.
本文引用的文献
1
Low-Density Lipoprotein Cholesterol Level, the Lower the Better? Analysis of Korean Patients in the Treat Stroke to Target Trial.低密度脂蛋白胆固醇水平，越低越好？对韩国参与“卒中治疗至靶目标”试验患者的分析
J Stroke. 2025 May;27(2):228-236. doi: 10.5853/jos.2025.00409. Epub 2025 May 31.
2
Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines.血脂水平及降脂治疗在不同程度脑动脉疾病的卒中患者中的作用：重新审视近期卒中指南
J Stroke. 2021 May;23(2):149-161. doi: 10.5853/jos.2021.01249. Epub 2021 May 31.
3
Benefit of Targeting a LDL (Low-Density Lipoprotein) Cholesterol <70 mg/dL During 5 Years After Ischemic Stroke.缺血性卒中风后 5 年内 LDL（低密度脂蛋白）胆固醇<70mg/dL 的获益。
Stroke. 2020 Apr;51(4):1231-1239. doi: 10.1161/STROKEAHA.119.028718. Epub 2020 Feb 20.
4
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.缺血性脑卒中后两种 LDL 胆固醇目标的比较。
N Engl J Med. 2020 Jan 2;382(1):9. doi: 10.1056/NEJMoa1910355. Epub 2019 Nov 18.
5
Different Influences of Statin Treatment in Preventing At-Risk Stroke Subtypes: A Post Hoc Analysis of J-STARS.他汀类药物治疗对不同类型高危卒中预防作用的影响：J-STARS 的事后分析。
J Atheroscler Thromb. 2020 May 1;27(5):449-460. doi: 10.5551/jat.50518. Epub 2019 Sep 18.
6
Ischemic stroke subtype classification: an asian viewpoint.缺血性脑卒中亚型分类：亚洲观点。
J Stroke. 2014 Jan;16(1):8-17. doi: 10.5853/jos.2014.16.1.8. Epub 2014 Jan 31.
7
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.阿托伐他汀降低颈动脉粥样硬化患者心血管事件风险：胆固醇水平积极降低预防卒中（SPARCL）试验的二次分析
Stroke. 2008 Dec;39(12):3297-302. doi: 10.1161/STROKEAHA.108.516450. Epub 2008 Oct 9.
8
High-dose atorvastatin after stroke or transient ischemic attack.中风或短暂性脑缺血发作后使用大剂量阿托伐他汀。
N Engl J Med. 2006 Aug 10;355(6):549-59. doi: 10.1056/NEJMoa061894.
Zotero 插件